Basics of pharmacovigilance

Drug safety and pharmacovigilance

Examining Drug Types in PV: Suspected and Concomitant

Welcome to our informative pharmacovigilance blog, where we shed light on the distinction between suspected drugs and concomitant drugs. Gain a deeper understanding of the roles and implications of suspected drugs in post-marketing surveillance and adverse event reporting.

Bala

Read

Drug safety and pharmacovigilance

Evaluation of Benefit-Risk Balance in Pharmacovigilance

In this detailed blog, we delve into the specific aspects of the benefit-risk evaluation process, accompanied by a flow diagram illustrating the sequential steps for proper implementation.

Bala

Read

Drug safety and pharmacovigilance

Pharmacovigilance – The Basics

In this comprehensive blog, where we provide a comprehensive overview of pharmacovigilance. Whether you’re new to the field or seeking a refresher, our blog is here to guide you through the basics of pharmacovigilance.

Bala

Read

Drug safety and pharmacovigilance

Understanding Action Items in pharmacovigilance

From this insightful blog, where you can learn all about action items and provide guidance on how to handle them promptly in various circumstances. By the end of this blog, you’ll have the knowledge to confidently address action items and drive progress.

Bala

Read

ICSR Management

Causality Assessment in PV: The Criteria and Category

Welcome to our blog, where we demystify the concept of causality assessment in the pharmacovigilance process. We understand that grasping the criteria and categories of causality assessment can sometimes be challenging. That’s why we’re here to simplify it for you, presenting the information in an easy-to-understand manner.

Bala

Read

Exploring Adverse Events

Counterfeit Drugs: An Adverse Event

In this comprehensive article, we delve into the world of counterfeit medicines. We explore what they are, how they are classified as adverse events, and the considerations involved.

Bala

Read

Drug safety and pharmacovigilance

Understanding Civil Money Penalties

In this pharmacovigilance blog, we will delve into the details of civil penalties, addressing any uncertainties regarding the amount of penalties for late submissions or the provision of misleading data. Take a moment to read and gain clarity through this blog. Happy reading!

Bala

Read

Drug safety and pharmacovigilance

Validating Incident Country: Key in Case Processing

Welcome to our informative pharmacovigilance blog, where we explore the significance of the country of incidence in ICSR (Individual Case Safety Report) case processing and its potential impact on the outcome of the case. Join in our journey through the world of pharmacovigilance.

Bala

Read